ArticleJournal of thrombosis and thrombolysis2023

COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.

Hikmat Abdel-Razeq et al.PubMed ↗Publisher ↗

No numbers read from the abstract.